Daiwa Securities Group »

Inhibrx Biosciences shares owned by Daiwa Securities Group

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Daiwa Securities Group from 13F filings

Historical chart of Daiwa Securities Group investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Daiwa Securities Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Daiwa Securities Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $66k 841 78.48

More positions owned by Daiwa Securities Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Welltower Inc Com reit (WELL)
Palantir Technologies Cl A (PLTR)
Netflix (NFLX)
Crowdstrike Hldgs Cl A (CRWD)
Digital Realty Trust (DLR)
Prologis (PLD)
Alphabet Cap Stk Cl C Put Option (GOOG)
Crown Castle Intl (CCI)

View all positions for Daiwa Securities Group

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
Sanofi
HighTower Advisors
BlackRock
Susquehanna International
Vanguard Group
Caligan Partners
Sofinnova Ventures
Capital Research Global Investors
State Street Corporation
Millennium Management
Healthcare Of Ontario Pension Plan Trust Fund
Partner Fund Management
Geode Capital Management

View all funds holding Inhibrx Biosciences